Literature DB >> 25480036

MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability.

Michelle A Wood-Trageser1, Fatih Gurbuz2, Svetlana A Yatsenko3, Elizabeth P Jeffries4, L Damla Kotan5, Urvashi Surti3, Deborah M Ketterer1, Jelena Matic1, Jacqueline Chipkin1, Huaiyang Jiang1, Michael A Trakselis4, A Kemal Topaloglu2, Aleksandar Rajkovic6.   

Abstract

Premature ovarian failure (POF) is genetically heterogeneous and manifests as hypergonadotropic hypogonadism either as part of a syndrome or in isolation. We studied two unrelated consanguineous families with daughters exhibiting primary amenorrhea, short stature, and a 46,XX karyotype. A combination of SNP arrays, comparative genomic hybridization arrays, and whole-exome sequencing analyses identified homozygous pathogenic variants in MCM9, a gene implicated in homologous recombination and repair of double-stranded DNA breaks. In one family, the MCM9 c.1732+2T>C variant alters a splice donor site, resulting in abnormal alternative splicing and truncated forms of MCM9 that are unable to be recruited to sites of DNA damage. In the second family, MCM9 c.394C>T (p.Arg132(∗)) results in a predicted loss of functional MCM9. Repair of chromosome breaks was impaired in lymphocytes from affected, but not unaffected, females in both families, consistent with MCM9 function in homologous recombination. Autosomal-recessive variants in MCM9 cause a genomic-instability syndrome associated with hypergonadotropic hypogonadism and short stature. Preferential sensitivity of germline meiosis to MCM9 functional deficiency and compromised DNA repair in the somatic component most likely account for the ovarian failure and short stature.
Copyright © 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25480036      PMCID: PMC4259971          DOI: 10.1016/j.ajhg.2014.11.002

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  A large-scale candidate gene association study of age at menarche and age at natural menopause.

Authors:  Chunyan He; Peter Kraft; Daniel I Chasman; Julie E Buring; Constance Chen; Susan E Hankinson; Guillaume Paré; Stephen Chanock; Paul M Ridker; David J Hunter
Journal:  Hum Genet       Date:  2010-08-24       Impact factor: 4.132

2.  Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks.

Authors:  Kohei Nishimura; Masamichi Ishiai; Kazuki Horikawa; Tatsuo Fukagawa; Minoru Takata; Haruhiko Takisawa; Masato T Kanemaki
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

3.  Colocalization of MCM8 and MCM7 with proteins involved in distinct aspects of DNA replication.

Authors:  Yayoi Kinoshita; Edward M Johnson; Ronald E Gordon; Heather Negri-Bell; Mark T Evans; Jennifer Coolbaugh; Yaseris Rosario-Peralta; Joseph Samet; Evelyn Slusser; Mark P Birkenbach; Dianne C Daniel
Journal:  Microsc Res Tech       Date:  2008-04       Impact factor: 2.769

Review 4.  The Mcm complex: unwinding the mechanism of a replicative helicase.

Authors:  Matthew L Bochman; Anthony Schwacha
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

5.  A new chromosome instability disorder.

Authors:  P Maraschio; D Peretti; S Lambiase; F Lo Curto; D Caufin; L Gargantini; L Minoli; O Zuffardi
Journal:  Clin Genet       Date:  1986-11       Impact factor: 4.438

6.  Replication of loci influencing ages at menarche and menopause in Hispanic women: the Women's Health Initiative SHARe Study.

Authors:  Christina T L Chen; Lindsay Fernández-Rhodes; Robert G Brzyski; Christopher S Carlson; Zhao Chen; Gerardo Heiss; Kari E North; Nancy F Woods; Aleksandar Rajkovic; Charles Kooperberg; Nora Franceschini
Journal:  Hum Mol Genet       Date:  2011-11-30       Impact factor: 6.150

7.  The MCM8-MCM9 complex promotes RAD51 recruitment at DNA damage sites to facilitate homologous recombination.

Authors:  Jonghoon Park; David T Long; Kyung Yong Lee; Tarek Abbas; Etsuko Shibata; Masamitsu Negishi; Yunhai Luo; John C Schimenti; Agnieszka Gambus; Johannes C Walter; Anindya Dutta
Journal:  Mol Cell Biol       Date:  2013-02-11       Impact factor: 4.272

8.  Identification, quantification, and evolutionary analysis of a novel isoform of MCM9.

Authors:  Elizabeth P Jeffries; William H Denq; William I Denq; Jonathan C Bartko; Michael A Trakselis
Journal:  Gene       Date:  2013-02-09       Impact factor: 3.688

9.  Mutational screening of SF1 and WNT4 in Tunisian women with premature ovarian failure.

Authors:  Besma Lakhal; Sonia Ben-Hadj-Khalifa; Nouha Bouali; Rim Braham; Elghezal Hatem; Ali Saad
Journal:  Gene       Date:  2012-08-23       Impact factor: 3.688

10.  Diagnosis of fanconi anemia: chromosomal breakage analysis.

Authors:  Anneke B Oostra; Aggie W M Nieuwint; Hans Joenje; Johan P de Winter
Journal:  Anemia       Date:  2012-05-24
View more
  54 in total

1.  A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing.

Authors:  Matthew S Bramble; Ellen H Goldstein; Allen Lipson; Tuck Ngun; Ascia Eskin; Jason E Gosschalk; Lara Roach; Neerja Vashist; Hayk Barseghyan; Eric Lee; Valerie A Arboleda; Daniel Vaiman; Zafer Yuksel; Marc Fellous; Eric Vilain
Journal:  Hum Reprod       Date:  2016-02-23       Impact factor: 6.918

2.  Novel STAG3 mutations in a Caucasian family with primary ovarian insufficiency.

Authors:  Abdelkader Heddar; Philippe Dessen; Delphine Flatters; Micheline Misrahi
Journal:  Mol Genet Genomics       Date:  2019-07-30       Impact factor: 3.291

3.  A mutation in the nucleoporin-107 gene causes XX gonadal dysgenesis.

Authors:  Ariella Weinberg-Shukron; Paul Renbaum; Rachel Kalifa; Sharon Zeligson; Ziva Ben-Neriah; Amatzia Dreifuss; Amal Abu-Rayyan; Noa Maatuk; Nilly Fardian; Dina Rekler; Moien Kanaan; Abraham O Samson; Ephrat Levy-Lahad; Offer Gerlitz; David Zangen
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

4.  Concerns regarding the potentially causal role of FANCA heterozygous variants in human primary ovarian insufficiency.

Authors:  Abdelkader Heddar; Micheline Misrahi
Journal:  Hum Genet       Date:  2020-11-05       Impact factor: 4.132

5.  An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome.

Authors:  Christiaan de Bruin; Verónica Mericq; Shayne F Andrew; Hermine A van Duyvenvoorde; Nicole S Verkaik; Monique Losekoot; Aleksey Porollo; Hernán Garcia; Yi Kuang; Dan Hanson; Peter Clayton; Dik C van Gent; Jan M Wit; Vivian Hwa; Andrew Dauber
Journal:  J Clin Endocrinol Metab       Date:  2015-03-05       Impact factor: 5.958

Review 6.  Genetics of human female infertility†.

Authors:  Svetlana A Yatsenko; Aleksandar Rajkovic
Journal:  Biol Reprod       Date:  2019-09-01       Impact factor: 4.285

7.  Mutations in the mitochondrial ribosomal protein MRPS22 lead to primary ovarian insufficiency.

Authors:  Anlu Chen; Dov Tiosano; Tulay Guran; Hagit N Baris; Yavuz Bayram; Adi Mory; Laura Shapiro-Kulnane; Craig A Hodges; Zeynep C Akdemir; Serap Turan; Shalini N Jhangiani; Focco van den Akker; Charles L Hoppel; Helen K Salz; James R Lupski; David A Buchner
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

Review 8.  Primary ovarian insufficiency in classic galactosemia: current understanding and future research opportunities.

Authors:  Mili Thakur; Gerald Feldman; Elizabeth E Puscheck
Journal:  J Assist Reprod Genet       Date:  2017-09-20       Impact factor: 3.412

Review 9.  Genomic insights into growth and its disorders: an update.

Authors:  Christiaan de Bruin; Andrew Dauber
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

10.  Primary Ovarian Insufficiency and Azoospermia in Carriers of a Homozygous PSMC3IP Stop Gain Mutation.

Authors:  Abdulmoein Eid Al-Agha; Ihab Abdulhamed Ahmed; Esther Nuebel; Mika Moriwaki; Barry Moore; Katherine A Peacock; Tim Mosbruger; Deborah W Neklason; Lynn B Jorde; Mark Yandell; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.